Dembe K, Jasik M, Piechna K
Kliniki Gastroenterologii i Chorób Przemiany Materii AM, Warszawie.
Pol Tyg Lek. 1994;49(1-3):19-20.
The study aimed at comparing an effectiveness of drugs increasing local blood flow injected into cavernous bodies of penis in the treatment of erective impotence in diabetic patients. Fifteen diabetic patients aged between 33 and 60 years with impotence lasting for 4 years have been selected. Patients have been treated with papaverine HCl in the dose of 20-40 mg, papaverine HCl in the same dose combined with phentolamine 5 mg, and prostaglandin E1 in the dose of 20 micrograms. Each patient has been all tested drugs. The most favourable results, i.e. most effective and without adverse reactions (priapism), have been produced by prostaglandin E1 which seems a drug of choice in the treatment of erective impotence in patients with long-lasting diabetes mellitus.
该研究旨在比较注入阴茎海绵体内的增加局部血流的药物在治疗糖尿病患者勃起功能障碍方面的有效性。选取了15名年龄在33至60岁之间、患有持续4年勃起功能障碍的糖尿病患者。患者分别接受20 - 40毫克剂量的盐酸罂粟碱、相同剂量盐酸罂粟碱与5毫克酚妥拉明联合用药,以及20微克剂量的前列腺素E1治疗。每位患者都接受了所有测试药物的治疗。前列腺素E1产生了最有利的结果,即最有效且无不良反应(持续性勃起),它似乎是治疗长期糖尿病患者勃起功能障碍的首选药物。